PEDIATRICS Vol. 63 No. 2 February 1979, pp. 301-319
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stiehm, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stiehm, E. R.

Standard and Special Human Immune Serum Globulins as Therapeutic Agents

E. Richard Stiehm M.D.1

1 Division of Immunology/Allergy, Department of Pediatrics, University of California School of Medicine, Los Angeles

Human ggr-globulin is a valuable and frequently prescribed biological used to provide passive immunity against microbial agents, toxins, or cells. ggr-Globulin is most widely used for the short-term prevention of certain bacterial or viral diseases when active immunization is unavailable (eg, hepatitis A) or when active immunization has not been given before exposure (eg, tetanus, rabies). ggr-Globulin is also indicated on a continuous basis in replacement therapy for persons with antibody immunodeficiency. It is also (mis)used by many physicians for colds, allergies, and recurrent infection despite lack of proved efficacy.

Two types of ggr-globulin preparations are available: standard human immune serum globulin (HISG) for general use, and special human immune serum globulins with a known antibody content for specific illnesses (Table I).

In addition, certain animal sera and antitoxins are available for passive immunity (Table I). Although a discussion of these agents is beyond the scope of this review, it is important to emphasize that their use is associated with considerable risk of adverse side reactions (anaphylaxis and serum sickness). Accordingly, the physician should know the exact indications for their use, always institute sensitivity testing, and be ready to treat side reactions immediately.1

SOME PROPERTIES OF IgG GLOBULIN

The immunoglobulins or "ggr-globulins" are the proteins of the plasma and tissue made in lymphoreticular tissues which have antibody activity.2 Although there are six classes of immunoglobulin—IgG, IgM, IgA, IgD, IgE, and secretory IgA—only IgG is present in significant quantities in HISG.

IgG is a glycoprotein with a molecular weight of 150,000 daltons distributed equally between the serum and the tissues.

Accepted on April 3, 1978




This article has been cited by other articles:


Home page
 Vet Rec.Home page
S. Adamantos and A. Boag
Thirteen cases of tetanus in dogs
Vet Rec., September 1, 2007; 161(9): 298 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Epidemiol RevHome page
J. D. Grabenstein, P. R. Pittman, J. T. Greenwood, and R. J.M. Engler
Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects
Epidemiol. Rev., August 1, 2006; 28(1): 3 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. Forrat, R. Dumas, M. Seiberling, M. Merz, C. Lutsch, and J. Lang
Evaluation of the Safety and Pharmacokinetic Profile of a New, Pasteurized, Human Tetanus Immunoglobulin Administered as Sham, Postexposure Prophylaxis of Tetanus
Antimicrob. Agents Chemother., February 1, 1998; 42(2): 298 - 305.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
F. T. Saulsbury
Varicella Pneumonia as the Presenting Manifestation of Immunodeficiency
Clinical Pediatrics, September 1, 1991; 30(9): 555 - 558.
[PDF]